Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Chronic Heart Failure

  Free Subscription


22.09.2025

1 Basic Res Cardiol
4 Circ Heart Fail
2 Circ Res
5 Eur J Heart Fail
1 Heart
1 Hypertension
2 Int J Cardiol
3 J Am Coll Cardiol
3 J Card Fail
2 J Cardiol
1 Lancet


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Basic Res Cardiol

  1. ERNY E, Koentges C, Mukherjee D, Wirth L, et al
    Downregulation of TCF19 and ATAD2 causes endothelial cell cycle arrest at the transition from cardiac hypertrophy to heart failure.
    Basic Res Cardiol. 2025 Sep 17. doi: 10.1007/s00395-025-01139.
    PubMed         Abstract available


    Circ Heart Fail

  2. FOX DK, Waken RJ, Wang F, Avula K, et al
    Changes in Heart Transplant Listings by Insurance and Race During the COVID Public Health Emergency.
    Circ Heart Fail. 2025 Aug 20:e012306. doi: 10.1161/CIRCHEARTFAILURE.124.012306.
    PubMed         Abstract available

  3. ZHANG X, Davison B, Adamo M, Arrigo M, et al
    Guideline-Directed Medical Therapy Use in the STRONG-HF Trial.
    Circ Heart Fail. 2025;18:e012716.
    PubMed         Abstract available

  4. CONDE-MARTEL A, Hernandez-Meneses M, Morales-Rull JL, Casado J, et al
    Hypokalemia During Decongestion With Loop Diuretics and Hydrochlorothiazide, a Post Hoc Analysis of the CLOROTIC Trial.
    Circ Heart Fail. 2025;18:e012914.
    PubMed         Abstract available

  5. MANCA P, Nuzzi V, Mule M, Sciacca S, et al
    Gaps and Knowledge in the Contemporary Management of Acute Right Ventricular Failure.
    Circ Heart Fail. 2025;18:e012030.
    PubMed         Abstract available


    Circ Res

  6. LI Z, LaPenna KB, Gehred ND, Yu X, et al
    Dysregulated Protein s-Nitrosylation Promotes Nitrosative Stress and Disease Progression in Heart Failure With Preserved Ejection Fraction.
    Circ Res. 2025 Sep 17. doi: 10.1161/CIRCRESAHA.124.326042.
    PubMed         Abstract available

  7. WU H, Zhuang Y, Yue Y, Liu J, et al
    SPOP Is a Key Trigger of Pathological Cardiac Hypertrophy and Heart Failure.
    Circ Res. 2025 Sep 15. doi: 10.1161/CIRCRESAHA.125.326129.
    PubMed         Abstract available


    Eur J Heart Fail


  8. Correction to "Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence".
    Eur J Heart Fail. 2025 Sep 15. doi: 10.1002/ejhf.70016.
    PubMed        

  9. ADAMO M, Pagnesi M, Chioncel O, Bayes-Genis A, et al
    Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.
    Eur J Heart Fail. 2025 Sep 15. doi: 10.1002/ejhf.70023.
    PubMed         Abstract available

  10. KOBAYASHI M, Duarte K, Ferreira JP, Baudry G, et al
    An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction.
    Eur J Heart Fail. 2025 Sep 16. doi: 10.1002/ejhf.70047.
    PubMed         Abstract available

  11. BOHM M, Butler J, Abdin A, Filippatos G, et al
    Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data from EMPEROR-Reduced.
    Eur J Heart Fail. 2025 Sep 16. doi: 10.1002/ejhf.70021.
    PubMed         Abstract available

  12. KNIERIM M, Hartmann N, Maurer W, Pabel S, et al
    Atrial fibrillation in end-stage heart failure: Cellular mechanisms behind CASTLE-HTx.
    Eur J Heart Fail. 2025 Sep 17. doi: 10.1002/ejhf.70051.
    PubMed        


    Heart

  13. LIAO LP, Church LA, Melville H, Jayasinghe T, et al
    Effect of ketone supplementation, a low-carbohydrate diet and a ketogenic diet on heart failure measures and outcomes: a systematic review and meta-analysis.
    Heart. 2025 Sep 16:heartjnl-2025-326082. doi: 10.1136/heartjnl-2025-326082.
    PubMed         Abstract available


    Hypertension

  14. PAN L, He X, Xu R, Bhattarai U, et al
    PHD2 Deletion in CD8(+) T Cells Worsens TAC-Induced Cardiac Inflammation, Heart Failure, and Pulmonary Remodeling.
    Hypertension. 2025 Sep 17. doi: 10.1161/HYPERTENSIONAHA.125.25284.
    PubMed         Abstract available


    Int J Cardiol

  15. LI L
    Re-evaluating composite CRP-based ratios in chronic heart failure: clarity beyond novelty.
    Int J Cardiol. 2025 Sep 12:133899. doi: 10.1016/j.ijcard.2025.133899.
    PubMed        

  16. ALAWAJNEH MM, Aljabali A, Theeb L, Tashtoush S, et al
    Predictors of discontinuation and non-publication of heart failure clinical trials: A cross-sectional analysis of ClinicalTrials.gov data.
    Int J Cardiol. 2025;442:133901.
    PubMed         Abstract available


    J Am Coll Cardiol

  17. KHAN SS, Damrauer SM
    Personalizing the Paradigm for Heart Failure Prevention.
    J Am Coll Cardiol. 2025;86:874-876.
    PubMed        

  18. PACKER M, Lam CSP, Butler J, Zannad F, et al
    Is Type 2 Diabetes a Modifiable Risk Factor for the Evolution and Progression of Heart Failure With a Preserved Ejection Fraction?
    J Am Coll Cardiol. 2025 Sep 17:S0735-1097(25)07341.
    PubMed         Abstract available

  19. CORDERO A, de la Espriella R, Nunez J
    Heart Failure Biomarkers for Atrial Fibrillation Prediction: Why Not CA125?
    J Am Coll Cardiol. 2025;86:e103-e104.
    PubMed        


    J Card Fail

  20. KISHIMORI T, Kato T, Wada A, Tani A, et al
    Comparative Outcomes of Tirzepatide and Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes.
    J Card Fail. 2025 Sep 12:S1071-9164(25)00376.
    PubMed        

  21. KODUR N, Gunsalus P, Milinovich A, Dalton JE, et al
    Evolving Natural History of Left Ventricular Ejection Fraction Recovery and Relapse in Heart Failure with Reduced Ejection Fraction.
    J Card Fail. 2025 Sep 11:S1071-9164(25)00378.
    PubMed         Abstract available

  22. BECHTHOLD AC, Ejem DB, McIlvennan CK, Matlock DD, et al
    Facilitators and Barriers to Values Discussions Following LVAD Implantation: Perspectives from Diverse Patients and Family Caregivers.
    J Card Fail. 2025;31:1393-1404.
    PubMed         Abstract available


    J Cardiol

  23. OKADA M, Inoue K, Onishi T, Tanaka N, et al
    Cardiothoracic Ratio as a Prognostic Marker in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2025 Sep 14:S0914-5087(25)00238-2. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available

  24. NISHINARITA R, Oikawa J, Arao K, Sugisaki K, et al
    Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation.
    J Cardiol. 2025 Apr 2:S0914-5087(25)00097-8. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available


    Lancet

  25. ROSSELLO X, Prescott EIB, Kristensen AMD, Latini R, et al
    beta blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials.
    Lancet. 2025 Aug 29:S0140-6736(25)01592-2. doi: 10.1016/S0140-6736(25)01592.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.